Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 278

1.

Performance of 18F-FDG, 11C-Methionine, and 18F-FET PET for Glioma Grading: A Meta-analysis.

Katsanos AH, Alexiou GA, Fotopoulos AD, Jabbour P, Kyritsis AP, Sioka C.

Clin Nucl Med. 2019 Jun 13. doi: 10.1097/RLU.0000000000002654. [Epub ahead of print]

PMID:
31205150
2.

Intraoperative Flow Cytometry for Diagnosis of Central Nervous System Lesions.

Alexiou GA, Vartholomatos G, Stefanaki K, Markopoulos GS, Kyritsis AP.

J Cytol. 2019 Apr-Jun;36(2):134-135. doi: 10.4103/JOC.JOC_45_18. No abstract available.

3.

Combination treatment for glioblastoma with temozolomide, DFMO and radiation.

Alexiou GA, Vartholomatos E, I Tsamis K, Peponi E, Markopoulos G, A Papathanasopoulou V, Tasiou I, Ragos V, Tsekeris P, Kyritsis AP, Galani V.

J BUON. 2019 Jan-Feb;24(1):397-404.

4.

Depression and quality of life in patients with epilepsy in Northwest Greece.

Siarava E, Hyphantis T, Katsanos AH, Pelidou SH, Kyritsis AP, Markoula S.

Seizure. 2019 Mar;66:93-98. doi: 10.1016/j.seizure.2019.02.012. Epub 2019 Feb 20.

PMID:
30818183
5.

Cancer-associated stroke: Pathophysiology, detection and management (Review).

Dardiotis E, Aloizou AM, Markoula S, Siokas V, Tsarouhas K, Tzanakakis G, Libra M, Kyritsis AP, Brotis AG, Aschner M, Gozes I, Bogdanos DP, Spandidos DA, Mitsias PD, Tsatsakis A.

Int J Oncol. 2019 Mar;54(3):779-796. doi: 10.3892/ijo.2019.4669. Epub 2019 Jan 2. Review.

6.

Antiproliferative and cytotoxic action of N-(p-coumaroyl) serotonin in lung cancer cells.

Mitsis M, Markopoulos G, Alexiou GA, Vartholomatos E, Lazari D, Hodaj E, Nastos D, Lianos G, Zagorianakou P, Galani V, Kyritsis AP.

J BUON. 2018 Nov-Dec;23(6):1693-1698.

7.

Skull Base Metastasis Revealed by Bone Scintigraphy in a Patient With Hypoglossal Nerve Palsy.

Katsanos AH, Sioka C, Chondrogiorgi M, Papadopoulos A, Fotopoulos A, Kyritsis AP, Ragos V.

Neurohospitalist. 2018 Oct;8(4):188-190. doi: 10.1177/1941874418755952. Epub 2018 Feb 13.

PMID:
30245769
8.

Intraoperative Immunophenotypic Analysis for Diagnosis and Classification of Primary Central Nervous System Lymphomas.

Vartholomatos G, Alexiou GA, Voulgaris S, Kyritsis AP.

World Neurosurg. 2018 Sep;117:464-465. doi: 10.1016/j.wneu.2018.03.022. No abstract available.

PMID:
30149427
9.

Clinical, neuroimaging and histopathological features of gliomatosis cerebri: a systematic review based on synthesis of published individual patient data.

Georgakis MK, Tsivgoulis G, Spinos D, Dimitriou NG, Kyritsis AP, Herrlinger U, Petridou ET.

J Neurooncol. 2018 Nov;140(2):467-475. doi: 10.1007/s11060-018-2976-4. Epub 2018 Aug 16.

PMID:
30117023
10.

Outcome factors in surgically treated patients for cervical spondylotic myelopathy.

Zika J, Alexiou GA, Giannopoulos S, Kastanioudakis I, Kyritsis AP, Voulgaris S.

J Spinal Cord Med. 2018 Jul 24:1-5. doi: 10.1080/10790268.2018.1500225. [Epub ahead of print]

PMID:
30040606
11.

Intraoperative cell cycle analysis for tumor margins evaluation: The future is now?

Vartholomatos G, Alexiou GA, Lianos GD, Harissis H, Voulgaris S, Kyritsis AP.

Int J Surg. 2018 May;53:380-381. doi: 10.1016/j.ijsu.2018.03.046. Epub 2018 Mar 29. No abstract available.

PMID:
29605577
12.

N-(p-coumaroyl) serotonin induces cell cycle arrest and apoptosis in breast cancer cells.

Mitsis M, Alexiou GA, Vartholomatos E, Markopoulos G, Lazari D, Hodaj E, Nastos D, Zagorianakou P, Galani V, Kyritsis AP.

J BUON. 2018 Jan-Feb;23(1):129-133.

13.

Detecting Myocardial Ischemia With 99mTechnetium-Tetrofosmin Myocardial Perfusion Imaging in Ischemic Stroke.

Giannopoulos S, Markoula S, Sioka C, Zouroudi S, Spiliotopoulou M, Naka KK, Michalis LK, Fotopoulos A, Kyritsis AP.

Neurohospitalist. 2017 Oct;7(4):164-168. doi: 10.1177/1941874417704752. Epub 2017 Apr 18.

14.

Restless legs syndrome and cerebrovascular/cardiovascular events: Systematic review and meta-analysis.

Katsanos AH, Kosmidou M, Konitsiotis S, Tsivgoulis G, Fiolaki A, Kyritsis AP, Giannopoulos S.

Acta Neurol Scand. 2018 Jan;137(1):142-148. doi: 10.1111/ane.12848. Epub 2017 Sep 25. Review.

PMID:
28948600
15.

Genetic and epigenetic alterations in meningiomas.

Galani V, Lampri E, Varouktsi A, Alexiou G, Mitselou A, Kyritsis AP.

Clin Neurol Neurosurg. 2017 Jul;158:119-125. doi: 10.1016/j.clineuro.2017.05.002. Epub 2017 May 3. Review.

PMID:
28527972
16.

Moschamine inhibits proliferation of glioblastoma cells via cell cycle arrest and apoptosis.

Alexiou GA, Lazari D, Markopoulos G, Vartholomatos E, Hodaj E, Galani V, Kyritsis AP.

Tumour Biol. 2017 May;39(5):1010428317705744. doi: 10.1177/1010428317705744.

PMID:
28475011
17.

Effectiveness of flow cytometry for brain tumor excision.

Alexiou GA, Vartholomatos G, Markopoulos GS, Voulgaris S, Kyritsis AP.

Photodiagnosis Photodyn Ther. 2017 Jun;18:323-324. doi: 10.1016/j.pdpdt.2017.04.016. Epub 2017 Apr 27. No abstract available.

PMID:
28457850
18.

High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: A systematic review and meta-analysis.

Fiolaki A, Katsanos AH, Kyritsis AP, Papadaki S, Kosmidou M, Moschonas IC, Tselepis AD, Giannopoulos S.

J Neurol Sci. 2017 May 15;376:112-116. doi: 10.1016/j.jns.2017.03.010. Epub 2017 Mar 9. Review.

PMID:
28431593
19.

In Vitro and In Vivo Preclinical Effects of Type I IFNs on Gliomas.

Galani V, Papadatos SS, Alexiou G, Galani A, Kyritsis AP.

J Interferon Cytokine Res. 2017 Apr;37(4):139-146. doi: 10.1089/jir.2016.0094. Epub 2017 Feb 17. Review.

PMID:
28387596
20.

N-(p-coumaroyl) serotonin inhibits glioblastoma cells growth through triggering S-phase arrest and apoptosis.

Lazari D, Alexiou GA, Markopoulos GS, Vartholomatos E, Hodaj E, Chousidis I, Leonardos I, Galani V, Kyritsis AP.

J Neurooncol. 2017 May;132(3):373-381. doi: 10.1007/s11060-017-2382-3. Epub 2017 Apr 1.

PMID:
28365838
21.

Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting.

Markoula S, Chatzistefanidis D, Gatzonis S, Siatouni A, Siarava E, Verentzioti A, Kyritsis AP, Patsalos PN.

Seizure. 2017 May;48:1-6. doi: 10.1016/j.seizure.2017.03.012. Epub 2017 Mar 19.

22.

99mTc-Tetrofosmin Uptake Correlates with the Sensitivity of Glioblastoma Cell Lines to Temozolomide.

Alexiou GA, Xourgia X, Gerogianni P, Vartholomatos E, Kalef-Ezra JA, Fotopoulos AD, Kyritsis AP.

World J Nucl Med. 2017 Jan-Mar;16(1):45-50. doi: 10.4103/1450-1147.181155.

23.

Difluoromethylornithine in cancer: new advances.

Alexiou GA, Lianos GD, Ragos V, Galani V, Kyritsis AP.

Future Oncol. 2017 Apr;13(9):809-819. doi: 10.2217/fon-2016-0266. Epub 2017 Jan 27. Review.

PMID:
28125906
24.

Multiple sclerosis and inflammatory bowel diseases: a systematic review and meta-analysis.

Kosmidou M, Katsanos AH, Katsanos KH, Kyritsis AP, Tsivgoulis G, Christodoulou D, Giannopoulos S.

J Neurol. 2017 Feb;264(2):254-259. doi: 10.1007/s00415-016-8340-8. Epub 2016 Nov 22. Review.

PMID:
27878439
25.

From bench to operating theater: has the time come for a molecular scalpel?

Vartholomatos G, Alexiou GA, Lianos GD, Kyritsis AP.

Future Oncol. 2017 Jan;13(2):121-123. Epub 2016 Nov 4. No abstract available.

PMID:
27809605
26.

Deferiprone Enhances Temozolomide Cytotoxicity in Glioma Cells.

Alexiou GA, Gerogianni P, Vartholomatos E, Kyritsis AP.

Cancer Invest. 2016 Nov 25;34(10):489-495. Epub 2016 Oct 21.

PMID:
27768402
27.

The value of transesophageal echocardiography for embolic strokes of undetermined source.

Katsanos AH, Bhole R, Frogoudaki A, Giannopoulos S, Goyal N, Vrettou AR, Ikonomidis I, Paraskevaidis I, Pappas K, Parissis J, Kyritsis AP, Alexandrov AW, Triantafyllou N, Malkoff MD, Voumvourakis K, Alexandrov AV, Tsivgoulis G.

Neurology. 2016 Sep 6;87(10):988-95. doi: 10.1212/WNL.0000000000003063. Epub 2016 Aug 3. Review.

28.

The role of diffusion tensor imaging and dynamic susceptibility perfusion MRI in the evaluation of meningioma grade and subtype.

Zikou A, Alexiou GA, Goussia A, Kosta P, Xydis V, Voulgaris S, Kyritsis AP, Argyropoulou MI.

Clin Neurol Neurosurg. 2016 Jul;146:109-15. doi: 10.1016/j.clineuro.2016.05.005. Epub 2016 May 6.

PMID:
27208870
29.

The diagnostic yield of transesophageal echocardiography in patients with cryptogenic cerebral ischaemia: a meta-analysis.

Katsanos AH, Giannopoulos S, Frogoudaki A, Vrettou AR, Ikonomidis I, Paraskevaidis I, Zompola C, Vadikolias K, Boviatsis E, Parissis J, Voumvourakis K, Kyritsis AP, Tsivgoulis G.

Eur J Neurol. 2016 Mar;23(3):569-79. doi: 10.1111/ene.12897. Epub 2015 Nov 19. Review.

PMID:
26918744
30.

Letter: Glioblastoma Resection Guided by Flow Cytometry.

Alexiou GA, Vartholomatos G, Voulgaris S, Kyritsis AP.

Neurosurgery. 2016 May;78(5):E761. doi: 10.1227/NEU.0000000000001218. No abstract available.

PMID:
26909806
31.

Transcranial Doppler versus transthoracic echocardiography for the detection of patent foramen ovale in patients with cryptogenic cerebral ischemia: A systematic review and diagnostic test accuracy meta-analysis.

Katsanos AH, Psaltopoulou T, Sergentanis TN, Frogoudaki A, Vrettou AR, Ikonomidis I, Paraskevaidis I, Parissis J, Bogiatzi C, Zompola C, Ellul J, Triantafyllou N, Voumvourakis K, Kyritsis AP, Giannopoulos S, Alexandrov AW, Alexandrov AV, Tsivgoulis G.

Ann Neurol. 2016 Apr;79(4):625-35. doi: 10.1002/ana.24609. Epub 2016 Mar 11. Review.

PMID:
26833864
32.

Expression of SRPK1 in gliomas and its role in glioma cell lines viability.

Sigala I, Tsamis KI, Gousia A, Alexiou G, Voulgaris S, Giannakouros T, Kyritsis AP, Nikolakaki E.

Tumour Biol. 2016 Jul;37(7):8699-707. doi: 10.1007/s13277-015-4738-7. Epub 2016 Jan 6.

PMID:
26738865
33.

Ischemic stroke risk factors during Greek economic crisis.

Katsanos AH, Fiolaki A, Markou S, Markoula S, Kosmidou M, Kyritsis AP, Giannopoulos S.

Atherosclerosis. 2016 Feb;245:118-22. doi: 10.1016/j.atherosclerosis.2015.12.013. Epub 2015 Dec 9.

PMID:
26717274
34.

The value of transesophageal echocardiography in the investigation and management of cryptogenic cerebral ischemia: a single-center experience.

Katsanos AH, Patsouras D, Tsivgoulis G, Kosmidou M, Katsanos KH, Kyritsis AP, Giannopoulos S.

Neurol Sci. 2016 Apr;37(4):629-32. doi: 10.1007/s10072-015-2448-y. Epub 2015 Dec 24.

PMID:
26705252
35.

Letter to the Editor: Intraoperative detection of glioma cells by flow cytometry.

Alexiou GA, Vartholomatos G, Voulgaris S, Kyritsis AP.

J Neurosurg. 2016 Feb;124(2):587-8. doi: 10.3171/2015.8.JNS151892. Epub 2015 Dec 18. No abstract available.

PMID:
26684778
36.

Cancer specific risk in multiple sclerosis patients.

Kyritsis AP, Boussios S, Pavlidis N.

Crit Rev Oncol Hematol. 2016 Feb;98:29-34. doi: 10.1016/j.critrevonc.2015.10.002. Epub 2015 Oct 9. Review.

PMID:
26481954
37.

Correlation of diffusion tensor and dynamic susceptibility contrast MRI with DNA ploidy and cell cycle analysis of gliomas.

Zikou A, Alexiou GA, Vartholomatos G, Goussia A, Xydis VG, Kosta P, Voulgaris S, Kyritsis AP, Argyropoulou MI.

Clin Neurol Neurosurg. 2015 Dec;139:119-24. doi: 10.1016/j.clineuro.2015.09.013. Epub 2015 Sep 26.

PMID:
26432994
38.

The effect of menarche age, parity and lactation on bone mineral density in premenopausal ambulatory multiple sclerosis patients.

Sioka C, Fotopoulos A, Papakonstantinou S, Georgiou A, Pelidou SH, Kyritsis AP, Kalef-Ezra JA.

Mult Scler Relat Disord. 2015 Jul;4(4):287-90. doi: 10.1016/j.msard.2015.05.006. Epub 2015 May 21.

PMID:
26195044
39.

Gender specific association of decreased bone mineral density in patients with epilepsy.

Markoula S, Sioka C, Exarchopoulos T, Chatzistefanidis D, Kalef-Ezra J, Fotopoulos A, Kyritsis AP.

Neurol Neurochir Pol. 2015;49(4):267-71. doi: 10.1016/j.pjnns.2015.06.007. Epub 2015 Jun 22.

PMID:
26188944
40.

GV/GA Sarissa-Lancet: A Proposed Real-Time Flow Cytometer for Intraoperative Identification of Glioma Margins.

Vartholomatos G, Alexiou GA, Batistatou A, Lykoudis E, Voulgaris S, Kyritsis AP.

Surg Innov. 2016 Feb;23(1):104-5. doi: 10.1177/1553350615589860. Epub 2015 Jun 16. No abstract available.

PMID:
26082179
41.

Targeting Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL): A Promising Therapeutic Strategy in Gliomas.

Alexiou GA, Tsamis KI, Kyritsis AP.

Semin Pediatr Neurol. 2015 Mar;22(1):35-9. doi: 10.1016/j.spen.2014.12.002. Epub 2014 Dec 11. Review.

PMID:
25976259
42.

Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells.

Alexiou GA, Tsamis KI, Vartholomatos E, Peponi E, Tzima E, Tasiou I, Lykoudis E, Tsekeris P, Kyritsis AP.

J Neurooncol. 2015 Jun;123(2):217-24. doi: 10.1007/s11060-015-1799-9. Epub 2015 May 3.

PMID:
25935110
43.

Is there a role for intraoperative flow cytometry in brain tumor surgery?

Vartholomatos G, Alexiou GA, Gerogianni P, Lykoudis E, Voulgaris S, Kyritsis AP.

Cytometry B Clin Cytom. 2015 Sep-Oct;88(5):289-90. doi: 10.1002/cyto.b.21235. No abstract available.

44.

Comparison of (99m)tc-tetrofosmin and (99m)tc-sestamibi uptake in glioma cell lines: the role of p-glycoprotein expression.

Alexiou GA, Xourgia X, Vartholomatos E, Tsiouris S, Kalef-Ezra JA, Fotopoulos AD, Kyritsis AP.

Int J Mol Imaging. 2014;2014:471032. doi: 10.1155/2014/471032. Epub 2014 Nov 10.

45.

Rapid cell cycle analysis for intraoperative diagnosis of brain tumors.

Vartholomatos G, Alexiou GA, Batistatou A, Lykoudis E, Voulgaris S, Kyritsis AP.

Brain Tumor Pathol. 2015 Apr;32(2):151-2. doi: 10.1007/s10014-014-0201-5. Epub 2014 Oct 21. No abstract available.

PMID:
25331691
46.

Embolization treatment of cerebral arteriovenous malformations and amyotrophic lateral sclerosis.

Katsavarou O, Ntampos S, Sarmas I, Triantafyllou N, Giannopoulos S, Kyritsis AP.

Neurol Sci. 2015 Mar;36(3):483-4. doi: 10.1007/s10072-014-1977-0. Epub 2014 Oct 7. No abstract available.

PMID:
25288160
47.

Expression of heat shock proteins in brain tumors.

Alexiou GA, Karamoutsios A, Lallas G, Ragos V, Goussia A, Kyritsis AP, Voulgaris S, Vartholomatos G.

Turk Neurosurg. 2014;24(5):745-9. doi: 10.5137/1019-5149.JTN.9852-13.0.

48.

Fast cell cycle analysis for intraoperative characterization of brain tumor margins and malignancy.

Alexiou GA, Vartholomatos G, Goussia A, Batistatou A, Tsamis K, Voulgaris S, Kyritsis AP.

J Clin Neurosci. 2015 Jan;22(1):129-32. doi: 10.1016/j.jocn.2014.05.029. Epub 2014 Aug 12.

PMID:
25124644
49.

Intraoperative cell-cycle analysis to guide brain tumor removal.

Vartholomatos G, Alexiou G, Batistatou A, Kyritsis AP.

Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):E3755. doi: 10.1073/pnas.1413155111. Epub 2014 Aug 13. No abstract available.

50.

Bortezomib-induced peripheral neurotoxicity: an update.

Argyriou AA, Cavaletti G, Bruna J, Kyritsis AP, Kalofonos HP.

Arch Toxicol. 2014 Sep;88(9):1669-79. doi: 10.1007/s00204-014-1316-5. Epub 2014 Jul 29. Review.

PMID:
25069804

Supplemental Content

Loading ...
Support Center